Clinical Trial

German Adrenocortical Carcinoma Registry

Recruiting
View on ClinicalTrials.gov →
Summary
Basic objective of the German Adrenocortical Carcinoma Registry is to improve the care of patients with adrenocortical cancer. The registration of as many patients as possible helps to collect data for the prognosis and prospects of success regarding different treatment plans. This data will be taken into consideration for planning prospective studies. With this registry, the recruitment of patients for prospective studies will be significantly facilitated. In this way - and in cooperation with networks in other countries (e.g. in Italy and France) - a structure allowing systematic improvement of therapy will be developed.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2007-03-28; most recent amendment 2026-05-01.
Trial Details
NCT Number NCT00453674
Lead Sponsor University of Wuerzburg
Collaborators: Deutsche Krebshilfe e.V., Bonn (Germany)
Conditions Adrenocortical Carcinoma
Enrollment 1,000 participants
Start Date 2003-01
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-07